Global Phage Therapy Kits Market Growth 2024-2030

Global Phage Therapy Kits Market Growth 2024-2030

Phage Therapy Kits refer to the use of bacteriophages, which are viruses that target and destroy specific bacterial strains, for the treatment of bacterial infections. These kits typically contain a selection of phages that can be used to treat infections that are resistant to antibiotics.

The global Phage Therapy Kits market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Phage Therapy Kits Industry Forecast” looks at past sales and reviews total world Phage Therapy Kits sales in 2023, providing a comprehensive analysis by region and market sector of projected Phage Therapy Kits sales for 2024 through 2030. With Phage Therapy Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Phage Therapy Kits industry.

This Insight Report provides a comprehensive analysis of the global Phage Therapy Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Phage Therapy Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Phage Therapy Kits market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Phage Therapy Kits and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Phage Therapy Kits.

United States market for Phage Therapy Kits is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Phage Therapy Kits is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Phage Therapy Kits is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Phage Therapy Kits players cover BiomX, PhagoMed Biopharma, Cytophage Technologies, MYRIADE, DotBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Phage Therapy Kits market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Medical Grade
Laboratory Grade

Segmentation by Application:
Medical
Food Industrial
Agriculture
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BiomX
PhagoMed Biopharma
Cytophage Technologies
MYRIADE
DotBio
Snipr Biome
CJ
Intralytix
iNtRON Biotechnology
Micreos

Key Questions Addressed in this Report

What is the 10-year outlook for the global Phage Therapy Kits market?

What factors are driving Phage Therapy Kits market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Phage Therapy Kits market opportunities vary by end market size?

How does Phage Therapy Kits break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.